Wells Fargo & Company Palatin Technologies Inc Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.27 - $0.5 $31 - $57	115 Added 8.87%	1,411 $0
Q1 2022 May 16, 2022	BUY	$0.37 - $0.54 $1 - $1	3 Added 0.23%	1,296 $1,000
Q4 2021 Feb 14, 2022	BUY	$0.34 - $0.86 $2 - $6	7 Added 0.54%	1,293 $1,000
Q3 2021 Nov 15, 2021	SELL	$0.44 - $0.63 $5,534 - $7,924	-12,578 Reduced 90.72%	1,286 $1,000
Q2 2021 Aug 16, 2021	SELL	$0.48 - $0.72 $4 - $7	-10 Reduced 0.07%	13,864 $9,000
Q1 2021 May 13, 2021	SELL	$0.68 - $1.25 $89,577 - $164,663	-131,731 Reduced 90.47%	13,874 $10,000
Q4 2020 Feb 09, 2021	SELL	$0.38 - $0.78 $75,693 - $155,371	-199,194 Reduced 57.77%	145,605 $99,000
Q3 2020 Nov 05, 2020	SELL	$0.47 - $0.64 $17,795 - $24,232	-37,863 Reduced 9.89%	344,799 $164,000
Q2 2020 Aug 13, 2020	SELL	$0.41 - $0.73 $70,419 - $125,381	-171,756 Reduced 30.98%	382,662 $196,000
Q1 2020 May 14, 2020	BUY	$0.36 - $0.79 $199,590 - $437,990	554,418 New	554,418 $235,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $10.8M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.